COTY vs EL: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: COTY is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. COTY and EL share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined COTY and EL exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Coty Inc is one of the world's largest beauty companies, operating through two reporting segments. Prestige, which makes up roughly two thirds of sales, is anchored by licensed luxury fragrances (Gucci, Burberry, Hugo Boss, Calvin Klein, Davidoff, Marc Jacobs, Chloe) plus owned or licensed makeup lines such as Kylie Cosmetics. Consumer Beauty covers mass-market cosmetics and skincare, including CoverGirl, Max Factor, Rimmel, Sally Hansen and Bourjois. The company was assembled largely through acquisitions, notably the 2016 purchase of Procter & Gamble beauty brands, which left it carrying a heavy debt load. Investment firm JAB remains the controlling shareholder with a majority stake, and Coty added a dual listing on the Paris Stock Exchange to broaden its investor base.

Full COTY guide

Estee Lauder sells prestige beauty across four categories: skin care (~$5.5 billion of net sales in the first nine months of fiscal 2026), makeup (~$3.3 billion), fragrance (~$2.2 billion) and hair care (~$0.4 billion). The portfolio spans roughly two dozen brands, including the namesake Estee Lauder line, La Mer, Clinique, M.A.C, Bobbi Brown, Too Faced, Smashbox, Dr.Jart+, Aveda, Origins, Le Labo, Jo Malone London, Tom Ford Beauty, Frederic Malle and The Ordinary. Distribution runs through department stores, perfumeries, specialty multi-brand retailers, freestanding stores, e-commerce, third-party marketplaces and travel retail, with the travel retail business reported inside the Asia/Pacific region. Geographically the company is split between the Americas (~$3.5 billion in the nine months), Europe, the UK, Ireland and emerging markets (~$2.9 billion), Asia/Pacific (~$2.8 billion) and Mainland China (~$2.2 billion), which makes China and Asian travel retail unusually important to results.

Full EL guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• COTY drivers: Prestige fragrance as the growth engine; Balance sheet repair and deleveraging.
• EL drivers: Margin recovery from the Profit Recovery and Growth Plan; China and Asian travel retail stabilising.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The biggest risk is execution: Coty is mid-turnaround with declining like-for-like revenue, weak US prestige fragrance market share, and a Consumer Beauty business that took a large non-cash impairment. For EL, reported earnings remain negative on a trailing twelve month basis, with a net loss of ~$248 million and EPS of ~-$0.69, so the valuation rests on adjusted and forward numbers rather than delivered GAAP profit.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick COTY if you believe its drivers more; EL if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the COTY and EL guides.

COTY. These figures are approximate and describe direction rather than precise values, and they can change quickly around a turnaround. Coty's results shift with fragrance demand, promotional intensity, currency and the pace of its strategic review. Reported numbers have been distorted by one-time items such as the Wella disposal loss and the Consumer Beauty impairment, so headline EPS and margins can differ a lot from adjusted figures. Always verify the latest quarterly release, balance sheet and any updated guidance from primary sources before making a decision.

EL. Priced against the midpoint of the company's own fiscal 2026 adjusted EPS guidance of ~$2.40, EL trades near ~37 times adjusted earnings, and closer to ~29 times consensus for the following year. No trailing price to earnings ratio exists because GAAP earnings are negative. The gap between a ~74.7% gross margin and a ~2.9% operating margin is where the whole debate sits: restructuring charges of ~$520 million in nine months plus the settlement charge sit between the two, and the multiple reflects an assumption that most of them do not repeat.

Headline figures (approximate, Jul 2026): COTY shows segments Prestige (~2/3 of sales, mostly fragrance) and Consumer Beauty (mass makeup/skincare), revenue trend Declining on a like-for-like basis through fiscal 2026, profitability Pressured; took a large non-cash Consumer Beauty impairment and posted a reported quarterly loss, debt / leverage Reduced sharply after the Wella sale to a near-decade low, but still meaningful; EL shows revenue (ttm) ~$14.8 billion, net income (ttm) ~-$248 million, EPS ~-$0.69, gross / operating margin (ttm) ~74.7% gross, ~2.9% operating, market capitalisation ~$32 billion at ~$88 per share.

COTY and EL are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined COTY and EL exposure against your real portfolio. It is not an investment adviser.